Veracyte, Inc.
VCYT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,028,806 | $1,998,450 | $1,697,863 | $2,797,082 |
| - Cash | $239,087 | $216,454 | $154,247 | $173,197 |
| + Debt | $50,737 | $12,630 | $14,718 | $18,853 |
| Enterprise Value | $2,840,456 | $1,794,626 | $1,558,334 | $2,642,738 |
| Revenue | $445,764 | $361,051 | $296,536 | $219,514 |
| % Growth | 23.5% | 21.8% | 35.1% | – |
| Gross Profit | $298,145 | $248,148 | $194,954 | $145,114 |
| % Margin | 66.9% | 68.7% | 65.7% | 66.1% |
| EBITDA | $49,205 | -$49,409 | -$6,981 | -$60,183 |
| % Margin | 11% | -13.7% | -2.4% | -27.4% |
| Net Income | $24,138 | -$74,404 | -$36,560 | -$75,563 |
| % Margin | 5.4% | -20.6% | -12.3% | -34.4% |
| EPS Diluted | 0.31 | -1.02 | -0.51 | -1.11 |
| % Growth | 130.4% | -100% | 54.1% | – |
| Operating Cash Flow | $75,096 | $44,222 | $7,535 | -$31,621 |
| Capital Expenditures | -$11,287 | -$9,961 | -$8,549 | -$5,376 |
| Free Cash Flow | $63,809 | $34,261 | -$1,014 | -$36,997 |